tiprankstipranks

Matthew Caufield Profile - H.C. Wainwright Analyst

312 Followers
tipranks
Matthew Caufield

Matthew Caufield
H.C. Wainwright

Wall Street Analyst
#2,291 out of 12,290 Wall Street Analysts
#4,953 out of 28,763 experts

Success Rate

38%
107 out of 279 ratings made a profit

Average Return

+8.30%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Matthew Caufield's trades since 2022 and holding each position for 1 Year would result in 38.35% of your transactions generating a profit, with an average return of 8.3% per rating.

Stock Rating Distribution

361Ratings
89.47% Buy
10.53% Hold
0.00% Sell
Distribution of Matthew Caufield's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Opus Genetics, Inc.
(IRD)
Rating:Buy
Date:Apr 01, 2025 - Apr 01, 2026
Return:+415.30%
The most profitable rating made by Matthew Caufield

Matthew Caufield's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Disc Medicine
Oct 21, 2022
Hold
Assigned
5Ratings
33%
-21.70%
RegenXBio
Oct 29, 2024
Buy
Reiterated
$39.00
(466.86% Upside)
1Ratings
100%
+41.70%
Hyperion DeFi
May 27, 2025
Hold
Assigned
20Ratings
0%
-73.20%
Opthea Limited Sponsored ADR
Aug 22, 2025
Hold
Assigned
10Ratings
25%
-17.96%
Lyra Therapeutics
Sep 17, 2025
Hold
Reiterated
$16.00
(2203.15% Upside)
13Ratings
0%
-89.68%
FibroBiologics, Inc.
Apr 16, 2026
Buy
Reiterated
$8.00
(647.66% Upside)
12Ratings
0%
-81.55%
Ardelyx
May 01, 2026
Buy
Reiterated
$18.00
(233.33% Upside)
7Ratings
29%
-3.70%
Phathom Pharmaceuticals
May 01, 2026
Buy
Reiterated
$26.00
(163.69% Upside)
19Ratings
35%
+21.16%
Akebia Therapeutics
May 08, 2026
Buy
Reiterated
$6.00
(518.37% Upside)
11Ratings
0%
-44.82%
Diamedica Therapeutics
May 08, 2026
Buy
Reiterated
$12.00
(105.48% Upside)
12Ratings
50%
+16.42%
List of latest recommendations made by Matthew Caufield. Click to expand and see Matthew Caufield's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Matthew Caufield activity FAQ

What is the performance of Matthew Caufield's recommendations?
The percentage of profitable recommendations made by Matthew Caufield is 38%, and the average return per transaction is 8.30%.
    What stocks does Matthew Caufield cover?
    Matthew Caufield mostly covers IRD ,ALDX ,FDMT stocks.
      What was Matthew Caufield's most profitable rating?
      Matthew Caufield’s most profitable ratings was a buy on IRD stock on Apr 01, 2025 - Apr 01, 2026. The return on the trade was +415.30%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here